PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease
Links shared publicly online about this topic.
- 168total visits
PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease
PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease
View full resource at pharmalive.com
Tags: COPD, Disease and Condition, FDA, Novartis, Pulmonology, disease
Most Recently Shared on July 5, 2011 at 6:20 pm By:
Daily Advantage - FDA OKs Novartis COPD Bronchodilator - http://tinyurl.com/3olyl92
Advertisement
